- Home
- ZIP vs MRVI Comparison
ZIP vs MRVI Comparison
Compare ZIP & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZIP
- MRVI
- Stock Information
- Founded
- ZIP 2010
- MRVI 2014
- Country
- ZIP United States
- MRVI United States
- Employees
- ZIP N/A
- MRVI N/A
- Industry
- ZIP Diversified Commercial Services
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- ZIP Consumer Discretionary
- MRVI Health Care
- Exchange
- ZIP Nasdaq
- MRVI Nasdaq
- Market Cap
- ZIP 427.4M
- MRVI 376.2M
- IPO Year
- ZIP 2021
- MRVI 2020
- Fundamental
- Price
- ZIP $3.97
- MRVI $3.34
- Analyst Decision
- ZIP Hold
- MRVI Hold
- Analyst Count
- ZIP 4
- MRVI 9
- Target Price
- ZIP $4.75
- MRVI $4.54
- AVG Volume (30 Days)
- ZIP 864.5K
- MRVI 1.4M
- Earning Date
- ZIP 11-05-2025
- MRVI 11-06-2025
- Dividend Yield
- ZIP N/A
- MRVI N/A
- EPS Growth
- ZIP N/A
- MRVI N/A
- EPS
- ZIP N/A
- MRVI N/A
- Revenue
- ZIP $450,401,000.00
- MRVI $219,830,000.00
- Revenue This Year
- ZIP N/A
- MRVI N/A
- Revenue Next Year
- ZIP $9.96
- MRVI $7.23
- P/E Ratio
- ZIP N/A
- MRVI N/A
- Revenue Growth
- ZIP N/A
- MRVI N/A
- 52 Week Low
- ZIP $3.35
- MRVI $1.67
- 52 Week High
- ZIP $11.25
- MRVI $8.54
- Technical
- Relative Strength Index (RSI)
- ZIP 30.83
- MRVI 69.44
- Support Level
- ZIP $3.97
- MRVI $2.94
- Resistance Level
- ZIP $4.36
- MRVI $3.30
- Average True Range (ATR)
- ZIP 0.27
- MRVI 0.20
- MACD
- ZIP -0.11
- MRVI 0.04
- Stochastic Oscillator
- ZIP 3.08
- MRVI 91.98
About ZIP ZipRecruiter Inc.
ZipRecruiter Inc is an online employment marketplace. It connects millions of job seekers with companies of all sizes. It is a two-sided marketplace for work that simplifies the job market for both job seekers and employers. Unlike traditional online job sites, ZipRecruiter works like a matchmaker curating job opportunities for job seekers, and candidates for employers.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.